September 13, 2010
CASE CCC IN THE NEWS
Cleveland Clinic Researcher Helps Organize International XMRV Meeting
Benefits Seen in Removing Healthy Ovaries in Women With Cancer Risk
Case CCC Scientific Series Wrap-Up
The Case CCC Scientific Series held on August 30 featured presentations by three of the four basic science of cancer pilot project teams. We had an impressive turnout to hear updates on the projects. Thanks to all of the presenters for a job well done! The next Case CCC Scientific Series is November 8.
Commentary by Dr. Susann Brady-Kalnay, Basic Science of Cancer Focus Groups Coordinating Group Member:
The August Scientific Series featured updates on three of the pilot projects funded by the Case CCC. A fourth project by Matthias Buck and Danny Manor was not be presented.
The first project by Drs. Cathy Carlin and John Wang summarized how two signaling labs began to investigate the cross talk of their signaling pathways that resulted in the regulation of adhesion-dependent events in cancer. This regulation of integrin adhesion-dependent signaling is a new area of research for these two investigators.
The second talk by Drs. Alex Almasan and Shigemi Matsuyama explained how their existing collaboration regarding cell cycle regulation was extended in new directions by pilot grant funding.
The third talk by Drs. Saba Valadkhan (co-investigator Dr. Phil Howe did not present) opened our eyes to a new area of investigation into the role of non-coding RNAs in signal transduction and cancer. Saba's research illustrates the depth of RNA research that exists in our outstanding RNA Center. Furthermore, her research gives us ideas about pursuing the role of RNA in our own projects with the new RNA core that is sponsored by the Cancer Center.
Susan G. Komen for the Cure
Susan G. Komen for the Cure Post-Baccalaureate Training in Disparities Research Grants are intended to establish a training program headed by a mentor to support qualified students who are dedicated to pursuing research in breast cancer disparities. Funding award will be individual support of up to $45,000 annually for 2 years with a 3rd year progress based option for up to three trainees.
Pre-Application Deadline: September 30
NCI Cancer Clinical Investigator Team Leadership Award
Dr. Smitha Krishnamurthi was awarded a Cancer Clinical Investigator Team Leadership Award from the NCI.
CTSC Pilot Awards
Dr. Catherine Demko was recently awarded a 2010 CTSC Annual Pilot Award.
Basic Science of Cancer Focus Group Updates
Message from Drs. Susann Brady-Kalnay and George Stark
The new focus groups will be:
Cytokine Signaling, Inflammation, and Cancer
Nuclear Receptor Signaling and Hormone Responsive Cancers
Tumor Microenvironment and Metastasis
We hope that everyone will continue to participate in as many focus groups as they have a scientific interest in. Please contact Tracy Rehl for more information.
The official Case CCC logo is available on the templates page of the Cancer Center website. Co-branded PowerPoint templates are also available on that page.
As a reminder, the NCI-designated Comprehensive Cancer Center logo may only be used in conjunction with the Case CCC logo.
MARK YOUR CALENDARS
Cell Death Regulation Program/ DNA Damage Response Meetings
As a follow up to the Cell Death Regulation (Program 2) mini retreat in June, the Program will be hosting a series of monthly meetings to examine topics in DNA damage response. The first meeting will be Thursday, September 16 from 4-6 pm in WRB 1402. Drs. Tom Radivoyevitch and Charles Kunos will present DNA damage Checkpoints and RNRM. There will be an open time at the end of the meeting to discuss related scientific efforts, potential collaboration, and other topics. Additional meetings will alternate between CWRU and the Cleveland Clinic. Light refreshments will be provided. Please RSVP to Kristin Waite. We look forward to seeing you there.
Science Café Cleveland
The October 11 Science Café Cleveland will feature Drs. Ruth Keri and Agata Exner, who will be presenting Pills and needles are so 20th century: How advancements in drug target discovery and drug delivery are shifting the strategy in the battle against cancer. Drinks start at 6:30 pm and discussion begins around 7 pm in the Tasting Room on the second floor of the Great Lakes Brewing Company. Science cafés provide an informal public forum for the open discussion of current science issues; they are based on the European salon model and many such cafés are currently active throughout much of the world.
2010 Cleveland Nanomedicine Summit
Registration is open for the 2010 Cleveland NanoMedicine Summit, October 18-19 at the InterContinental Hotel. Co-hosted by the Cleveland Clinic and CWRU, this event will continue its incredibly successful format that brings together scientists, clinicians, business professionals, investors, and others to investigate sustainable solutions of multidisciplinary methodologies to further advance the use of nanomedicine in clinical practice. Clinical and research abstracts on the topic of nanoparticles for diagnostics, imaging, and therapeutics will be accepted through October 1. Cancer Center members Drs. Vinod Labhasetwar, James Basilion and Maciej Zborowski are on the Organizing Committee.
Graft versus Host Disease Conference
Together with the Case CCC, the Meredith A. Cowden Foundation presents the 2010 National GVHD Symposium to be held at Corporate College East on Thursday, November 4. This unique one-day program will be a two-track conference (one for physicians and one for patients) focusing on cutting edge research and new treatments. Continuing medical education credits will be offered for attending and participating medical providers.
Featured Case CCC presenters include: Drs. Stan Gerson, Ken Cooke, Matt Kalaycio and Jeff Auletta.
NCI CANCER BULLETIN
**All events are open to anyone interested in attending
David Satcher Lecture Series
Pathology Research Seminar
Physiology and Biophysics Seminar
Department of Medicine Grand Rounds
Taussig Cancer Institute Core Curriculum Series
Developmental Therapeutics Program (DTP) meeting canceled
ICC Grand Rounds
CWRU SOM Louis A. Bloomfield Lecture
LRI Showcase Seminar
Cell Death Regulation Program/ DNA Damage Response Meeting
Hematology and Oncology Fellows
Taussig Cancer Institute Grand Rounds
Neurosciences Thesis Defense
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Cancer Center Scientific Series
ADDITIONAL UPCOMING SEMINARS & EVENTS
2010 caBIG Annual Meeting: Building a Collaborative Biomedical Network
Third Annual Personalized Health Care National Conference
2010 Cleveland Nanomedicine Summit
International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy
ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer
2010 International Conference of RNA Nanotechnology and Therapeutics
Graft versus Host Disease Conference
Active Living Research Annual Conference
Call for Abstracts: 2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Choose Ohio First Scholarship And Tomas & Evelyn James Fellowship In Bioinformatics, Computational Biology and Medical Informatics
AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.